Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation

被引:14
作者
Weisdorf, DJ
DeFor, T
Nichol, J
Panoskaltsis-Mortari, A
Blazar, BR
机构
[1] Univ Minnesota, Blood & Marrow Transplant Program, Minneapolis, MN USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
thrombopoietin; IL-11; IL-6; platelets; BMT;
D O I
10.1038/sj.bmt.1702221
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
In order to evaluate the importance of different thrombopoietic stimulatory cytokines in accelerating platelet recovery after bone marrow transplantation (BMT), we assayed serial plasma concentrations of three cytokines, thrombopoietin (TPO), interleukin-6 (IL-6), and IL-11 through the course of platelet nadir and recovery after BMT, Both mean TPO and IL-6 levels showed a marked rise and later fall preceding or coincident with the platelet nadir and recovery, suggesting their potential role as circulating regulators or stimulators of thrombopoiesis, In contrast, IL-11 levels remained remarkably constant through the whole course suggesting that this cytokine, though capable of stimulating thrombopoiesis, does not serve as a circulating regulator of platelet production. Additionally, we assayed the levels of these three cytokines following initial platelet transfusion to assess the capacity of transfused platelets to adsorb these thrombopoietic cytokines from the plasma and reduce their circulating levels, thus potentially modifying their availability for stimulating megakaryocyte proliferation, No consistent falls in TPO, IL-6 or IL-11 levels were observed following the initial two platelet transfusions. These data support the importance of circulating TPO and IL-6 as hormones capable of stimulating platelet production. Their physiologic relevance as in vivo regulators of thrombopoiesis and clinical utility for therapy of thrombocytopenia need further investigation.
引用
收藏
页码:711 / 715
页数:5
相关论文
共 33 条
[1]  
BAIOCCHI G, 1993, CANCER RES, V53, P1297
[2]  
Bernstein S. H., 1995, Blood, V86, p46A
[3]   Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin [J].
Bunting, S ;
Widmer, R ;
Lipari, TR ;
Rangell, L ;
Steinmetz, H ;
CarverMoore, K ;
Moore, MW ;
Keller, GA ;
deSauvage, FJ .
BLOOD, 1997, 90 (09) :3423-3429
[4]   LEUKEMIA INHIBITORY FACTOR AND INTERLEUKIN-11 PROMOTE MATURATION OF MURINE AND HUMAN MEGAKARYOCYTES INVITRO [J].
BURSTEIN, SA ;
MEI, RL ;
HENTHORN, J ;
FRIESE, P ;
TURNER, K .
JOURNAL OF CELLULAR PHYSIOLOGY, 1992, 153 (02) :305-312
[5]   Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: Insight into the regulation of platelet production [J].
Chang, M ;
Suen, Y ;
Meng, G ;
Buzby, JS ;
Bussel, J ;
Shen, V ;
vandeVen, C ;
Cairo, MS .
BLOOD, 1996, 88 (09) :3354-3362
[6]  
CHASTY RC, 1993, BONE MARROW TRANSPL, V12, P331
[7]  
DU XX, 1993, BLOOD, V81, P27
[8]   Interleukin-11: Review of molecular, cell biology, and clinical use [J].
Du, XX ;
Williams, DA .
BLOOD, 1997, 89 (11) :3897-3908
[9]   Regulation of thrombopoietin levels by c-mpl - Mediated binding to platelets [J].
Fielder, PJ ;
Gurney, AL ;
Stefanich, E ;
Marian, M ;
Moore, MW ;
CarverMoore, K ;
deSauvage, FJ .
BLOOD, 1996, 87 (06) :2154-2161
[10]   Cytokine production and function in c-mpl-deficient mice:: No physiologic role for interleukin-3 in residual megakaryocyte and platelet production [J].
Gainsford, T ;
Roberts, AW ;
Kimura, S ;
Metcalf, D ;
Dranoff, G ;
Mulligan, RC ;
Begley, CG ;
Robb, L ;
Alexander, WS .
BLOOD, 1998, 91 (08) :2745-2752